Special exams for students who can't appear for final year exams in September: UGC to SC

The UGC statement came in response to a petition filed in the apex court by some students, including one COVID-positive student, opposing the decision to make term-end exams compulsory.

Moneycontrol News

July 30, 2020 / 09:22 PM IST

Representative image

The University Grants Commission (UGC) on July 30 informed the Supreme Court that it will let universities conduct “special exams” for students who would not be able to appear for the term-end examinations in September.

Several states, including Maharashtra and Delhi, had opposed UGC's mandate that final year and final semester exams be held by September-end.

They had even issued directives stating that state-run universities will not hold term-end exams as it may pose a risk to the well-being of students.

However, UGC said a decision to cancel exams for under-graduate/post-graduate students and confer them with degrees without appearing for the final year exams "is plainly contrary to the UGC guidelines".

According to a report in The Indian Express, UGC told the Supreme Court that "all universities or institutions are obligated to conduct a terminal semester or final year exam by the end of September 2020".

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show